166 related articles for article (PubMed ID: 22585683)
1. Mucin as a therapeutic target in pseudomyxoma peritonei.
Choudry HA; O'Malley ME; Guo ZS; Zeh HJ; Bartlett DL
J Surg Oncol; 2012 Dec; 106(7):911-7. PubMed ID: 22585683
[TBL] [Abstract][Full Text] [Related]
2. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation.
Yan H; Pestieau SR; Shmookler BM; Sugarbaker PH
Mod Pathol; 2001 Mar; 14(3):164-71. PubMed ID: 11266521
[TBL] [Abstract][Full Text] [Related]
3. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells.
O'Connell JT; Tomlinson JS; Roberts AA; McGonigle KF; Barsky SH
Am J Pathol; 2002 Aug; 161(2):551-64. PubMed ID: 12163380
[TBL] [Abstract][Full Text] [Related]
4. MUC2 is a molecular marker for pseudomyxoma peritonei.
O'Connell JT; Hacker CM; Barsky SH
Mod Pathol; 2002 Sep; 15(9):958-72. PubMed ID: 12218214
[TBL] [Abstract][Full Text] [Related]
5. Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei.
Buell-Gutbrod R; Gwin K
Am Soc Clin Oncol Educ Book; 2013; ():221-5. PubMed ID: 23714507
[TBL] [Abstract][Full Text] [Related]
6. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
7. Pseudomyxoma peritonei (mucinous carcinoma peritonei) preceded by intraductal papillary neoplasm of the bile duct.
Jhuang JY; Hsieh MS
Hum Pathol; 2012 Jul; 43(7):1148-52. PubMed ID: 22406366
[TBL] [Abstract][Full Text] [Related]
8. [Pseudomyxoma peritonei arising from urachal carcinoma].
Nakamura K; Terada N; Shimizu Y; Kobayashi T; Sugino Y; Yamasaki T; Matsui Y; Imamura M; Okubo K; Kamba T; Yoshimura K; Ogawa O
Hinyokika Kiyo; 2013 Oct; 59(10):657-62. PubMed ID: 24262707
[TBL] [Abstract][Full Text] [Related]
9. [Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies].
Dartigues P; Isaac S; Villeneuve L; Glehen O; Capovilla M; Chevallier A; Croce S; Kaci R; Lang-Averous G; Laverriere MH; Leroux-Broussier A; Mery É; Poizat F; Valmary-Degano S; Verriele-Beurrier V; Gilly FN; Bibeau F
Ann Pathol; 2014 Feb; 34(1):14-25. PubMed ID: 24630633
[TBL] [Abstract][Full Text] [Related]
10. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process.
Mohamed F; Gething S; Haiba M; Brun EA; Sugarbaker PH
J Surg Oncol; 2004 Apr; 86(1):10-5. PubMed ID: 15048674
[TBL] [Abstract][Full Text] [Related]
11. The coexistence of low-grade mucinous neoplasms of the appendix and appendiceal diverticula: a possible role in the pathogenesis of pseudomyxoma peritonei.
Lamps LW; Gray GF; Dilday BR; Washington MK
Mod Pathol; 2000 May; 13(5):495-501. PubMed ID: 10824920
[TBL] [Abstract][Full Text] [Related]
12. The etiology, clinical presentation, and management of pseudomyxoma peritonei.
Moran BJ; Cecil TD
Surg Oncol Clin N Am; 2003 Jul; 12(3):585-603. PubMed ID: 14567019
[TBL] [Abstract][Full Text] [Related]
13. Mesenteric cyst: report of a case-resulting in pseudomyxoma peritonei.
Zappa L; Sugarbaker PH
Tumori; 2010; 96(2):332-5. PubMed ID: 20572595
[TBL] [Abstract][Full Text] [Related]
14. In vivo model of pseudomyxoma peritonei for novel candidate drug discovery.
Chua TC; Akther J; Yao P; Morris DL
Anticancer Res; 2009 Oct; 29(10):4051-5. PubMed ID: 19846950
[TBL] [Abstract][Full Text] [Related]
15. Management of pseudomyxoma peritonei.
Fallis SA; Moran BJ
J BUON; 2015 May; 20 Suppl 1():S47-55. PubMed ID: 26051332
[TBL] [Abstract][Full Text] [Related]
16. Role of Epithelial-Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments.
Calabrò ML; Lazzari N; Rigotto G; Tonello M; Sommariva A
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266161
[TBL] [Abstract][Full Text] [Related]
17. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects.
Amini A; Masoumi-Moghaddam S; Ehteda A; Morris DL
Orphanet J Rare Dis; 2014 May; 9():71. PubMed ID: 24886459
[TBL] [Abstract][Full Text] [Related]
18. Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei).
Moran B; Baratti D; Yan TD; Kusamura S; Deraco M
J Surg Oncol; 2008 Sep; 98(4):277-82. PubMed ID: 18726894
[TBL] [Abstract][Full Text] [Related]
19. Mucinous Balls Tangled With Mesothelial Cells and MUC2-Positive Cancer Cells in the Ascites of Pseudomyxoma Peritonei.
Akashi S; Kuwabara H; Yasuda E; Akutagawa H; Takeshita A; Kurisu Y; Egashira Y; Hirose Y; Yuki M; Tsuda Y; Hayashi M
Diagn Cytopathol; 2016 Jul; 44(7):628-31. PubMed ID: 27079739
[TBL] [Abstract][Full Text] [Related]
20. [Conservative treatment of pseudomyxoma peritonei].
Machado MA; Rodrigues JG; Laurino RM; Garrido Júnior A; Pinotti HW
Rev Hosp Clin Fac Med Sao Paulo; 1993; 48(6):301-4. PubMed ID: 8029605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
